Navegar por autor "Pombo Suárez, Manuel"

Mostrando ítems 1-5 de 5

Drug retention of biological DMARD in rheumatoid arthritis patients: the role of baseline characteristics and disease evolution

2019- Lauper, K.; Mongin, D.; Alpizar-Rodriguez, D.; Codreanu, C.; Iannone, F.; [et al.]
Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the 'JAK-pot' collaboration

2022- Lauper, K.; Iudici, M.; Mongin, D.; Bergstra, S.A.; Choquette, D.; [et al.]
Four-years retention rate of golimumab administered after discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases

2023- Pombo Suárez, Manuel; Seoane-Mato, D.; Díaz-González, F.; Sánchez-Alonso, F.; Sánchez-Jareño, M.; [et al.]
Long-term retention of golimumab treatment in clinical practice in a large cohort of patients with rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis

2023- Pombo Suárez, Manuel; Seoane-Mato, D.; Díaz-González, F.; Cea-Calvo, L.; Sánchez-Alonso, F.; [et al.]
Role of diabetes in the clinical outcome of patients submitted to a myocardical perfusion SPECT

2011- González Juanatey, José Ramón; Vidal Pérez, Rafael Carlos; Pena Álvarez, Carolina; Ruibal Morell, Alvaro; Pombo Suárez, Manuel; [et al.]